Your browser doesn't support javascript.
loading
The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study.
Atci, Muhammed Mustafa; Akagunduz, Baran; Demir, Metin; Arikan, Rukiye; Ay, Seval; Ozer, Muhammet; Ayhan, Murat; Cil, Ibrahim; Demir, Nazan; Ozyurt, Neslihan; Karakaya, Gökhan; Cevik, Gokcen Tugba; Onder, Arif Hakan; Selvi, Oguzhan; Sakin, Abdullah.
Afiliación
  • Atci MM; Department of Medical Oncology, University of Health Sciences, Professor Doctor Cemil Tascioglu Istanbul City Hospital, Istanbul, Turkey.
  • Akagunduz B; Department of Medical Oncology, Erzincan Binali Yildriim University Medical School, Erzincan, Turkey.
  • Demir M; Department of Medical Oncology, Erzurum Training and Research Hospital, Erzurum, Turkey.
  • Arikan R; Department of Medical Oncology, Marmara University Medical School, Istanbul, Turkey.
  • Ay S; Department of Medical Oncology, Istanbul Medeniyet University, Goztepe Education and Research Hospital, Istanbul, Turkey.
  • Ozer M; Department of Internal Medicine, Capital Health Regional Medical Center, Trenton, United States.
  • Ayhan M; Department of Medical Oncology, Kartal Lutfi Kirdar Research Hospital, Istanbul, Turkey.
  • Cil I; Department of Medical Oncology, University of Health Sciences, Umraniye training and Research hospital, Istanbul, Turkey.
  • Demir N; Department of Medical Oncology, Eskisehir Osmangazi University Medical School, Eskisehir.
  • Ozyurt N; Department of Medical Oncology, Giresun Research Hospital, Giresun, Turkey.
  • Karakaya G; Department of Medical Oncology, Mardin, Research Hospital, Mardin, Turkey.
  • Cevik GT; Department of Medical Oncology, Usak Research Hospital, Usak, Turkey.
  • Onder AH; Department of Medical Oncology, University of Health Sciences, Antalya training and Research hospital, Antalya, Turkey.
  • Selvi O; Department of Medical Oncology, University of Health Sciences, Professor Doctor Cemil Tascioglu Istanbul City Hospital, Istanbul, Turkey.
  • Sakin A; Department of Medical Oncology, University of Health Sciences, Professor Doctor Cemil Tascioglu Istanbul City Hospital, Istanbul, Turkey.
J Chemother ; 35(1): 19-28, 2023 Feb.
Article en En | MEDLINE | ID: mdl-35174772
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Colon Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Chemother Asunto de la revista: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Turquía
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Colon Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Chemother Asunto de la revista: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Turquía